Precision medicine in epilepsy: 'Don't raise patient expectations'

A real-world study across six specialist centres suggests genetic testing leads to therapeutic improvements in only a small minority of patients

Precision medicine in epilepsy has a long way to go before it can reliably be expected to produce therapeutic benefits in the way that is being seen in oncology, leading neurologists say.

genes, DNA

In fact, therapy changes that are not rationally based on genetic testing results seem to be more effective than those that are, a study suggests.

UK-led neurologists examined a real-world cohort of 293 adults and children with epilepsy (45% male, 53% adults) from six highly-specialised epilepsy centres across the UK,